Peo, Laura-Carlotta
Wiehler, Katharina
Paulick, Johannes
Gerrer, Katrin
Leone, Ariane
Viereck, Anja
Haegele, Matthias
Stojanov, Silvia
Warlitz, Cordula
Augustin, Silvia
Alberer, Martin
Hattesohl, Daniel B. R.
Froehlich, Laura
Scheibenbogen, Carmen
Jason, Leonard A.
Mihatsch, Lorenz L.
Pricoco, Rafael
Behrends, Uta
Funding for this research was provided by:
Weidenhammer-Zoebele Foundation
Lost Voices Foundation
Federal Ministry of Health
Bavarian State Ministry of Health and Care
Technische Universität München
Article History
Received: 7 September 2023
Revised: 7 November 2023
Accepted: 23 November 2023
First Online: 14 December 2023
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics of the University Hospital of the Technical University of Munich (116/21, 511/21).
: Written informed consent was obtained from all subjects (or their legal guardian) involved in the study.
: Written informed consent was obtained from all subjects (or their legal guardian) involved in the study.
: U.B. received research grants from the Federal Ministry of Education and Research (BMBF), the BMG, the Bavarian State Ministry of Health and Care (StMGP), the Bavarian State Ministry of Science and the Arts (StMWK), the German Center for Infection Research (DZIF), the People for Children (Menschen für Kinder) foundation, the WZS, the LVS, and the ME/CFS research foundation (ME/CFS RF). C.S. was consulting Roche, Celltrend, and Bayer; she received support for clinical trials by Bayer, Fresenius, and Miltenyi, honoraria for lectures by Fresenius, AstraZeneca, BMS, Roche, Bayer, and Novartis, and research grants from the German Research Association (DFG), the BMBF, the BMG, the WZS, the LVS, and the ME/CFS RF. The other authors declare no conflict of interest.